uric acid has been researched along with Infant, Small for Gestational Age in 14 studies
Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.
Infant, Small for Gestational Age: An infant having a birth weight lower than expected for its gestational age.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Pregnant women were divided into hyperuricemia-HU (uric acid ≥ 6 mg/dL) or normouricemia (uric acid, 2." | 8.12 | Serum uric acid levels associated with biochemical parameters linked to preeclampsia severity and to adverse perinatal outcomes. ( da Silva, JVF; de Mendonça, ELSS; de Oliveira, ACM; Mello, CS, 2022) |
| "This study aims to ascertain whether serum uric acid is a suitable predictor of preeclampsia and/or the delivery of small-for-gestational-age infants for women with gestational hypertension." | 8.02 | Uric acid levels in gestational hypertensive women predict preeclampsia and outcome of small-for-gestational-age infants. ( Duan, T; Frempong, ST; Zhao, X, 2021) |
| "We asked, is uric acid as effective as proteinuria at identifying perinatal risk in high-risk women with gestational hypertension? Uric acid was measured in samples obtained ≈4." | 7.81 | Uric Acid Determination in Gestational Hypertension: Is it as Effective a Delineator of Risk as Proteinuria in High-Risk Women? ( Althouse, AD; Clifton, RG; Roberts, JM; Schmella, MJ, 2015) |
| " Women were grouped according to diagnosis (pre-eclampsia or gestational hypertension) and logistic regression analysis was used to determine the relationship between uric acid, haemoglobin, haematocrit and adverse outcomes; an α level of P < 0." | 7.78 | Plasma uric acid remains a marker of poor outcome in hypertensive pregnancy: a retrospective cohort study. ( Brown, MA; Davis, GK; Hawkins, TL; Mangos, GJ; Roberts, JM; Roberts, LM, 2012) |
| "First trimester elevated uric acid was associated with later pre-eclampsia and more strongly with pre-eclampsia and gestational hypertension with hyperuricemia." | 7.77 | First trimester uric acid and adverse pregnancy outcomes. ( Catov, J; Gandley, RE; Laughon, SK; Powers, RW; Roberts, JM, 2011) |
| "Maximum serum uric acid (SUA) levels during the third trimester of pregnancy were selected in 215 hypertensive pregnant women: 100 with mild preeclampsia (PE), 25 with severe PE, 70 with essential hypertension (EH) and 20 with EH with superimposed PE (EH + PE)." | 7.67 | Uric acid levels: a useful index of the severity of preeclampsia and perinatal prognosis. ( Darbon-Grosso, HA; Illia, R; Imaz, FU; Margulies, M; Voto, LS, 1988) |
| " Pregnant women were divided into hyperuricemia-HU (uric acid ≥ 6 mg/dL) or normouricemia (uric acid, 2." | 4.12 | Serum uric acid levels associated with biochemical parameters linked to preeclampsia severity and to adverse perinatal outcomes. ( da Silva, JVF; de Mendonça, ELSS; de Oliveira, ACM; Mello, CS, 2022) |
| "This study aims to ascertain whether serum uric acid is a suitable predictor of preeclampsia and/or the delivery of small-for-gestational-age infants for women with gestational hypertension." | 4.02 | Uric acid levels in gestational hypertensive women predict preeclampsia and outcome of small-for-gestational-age infants. ( Duan, T; Frempong, ST; Zhao, X, 2021) |
| " The aim of this analysis was to describe the relationship of maternal serum uric acid (SUA) and cystatin C with maternal and neonatal cardiometabolic risk markers and with birth weight and risk of small-for-gestational age (SGA) as well as large-for gestational age (LGA)." | 3.88 | Association of maternal uric acid and cystatin C serum concentrations with maternal and neonatal cardiovascular risk markers and neonatal body composition: The Ulm SPATZ Health Study. ( Braig, S; Feike, G; Genuneit, J; Koenig, W; Logan, CA; Müller, M; Reister, F; Rothenbacher, D, 2018) |
| "We asked, is uric acid as effective as proteinuria at identifying perinatal risk in high-risk women with gestational hypertension? Uric acid was measured in samples obtained ≈4." | 3.81 | Uric Acid Determination in Gestational Hypertension: Is it as Effective a Delineator of Risk as Proteinuria in High-Risk Women? ( Althouse, AD; Clifton, RG; Roberts, JM; Schmella, MJ, 2015) |
| " Women were grouped according to diagnosis (pre-eclampsia or gestational hypertension) and logistic regression analysis was used to determine the relationship between uric acid, haemoglobin, haematocrit and adverse outcomes; an α level of P < 0." | 3.78 | Plasma uric acid remains a marker of poor outcome in hypertensive pregnancy: a retrospective cohort study. ( Brown, MA; Davis, GK; Hawkins, TL; Mangos, GJ; Roberts, JM; Roberts, LM, 2012) |
| "First trimester elevated uric acid was associated with later pre-eclampsia and more strongly with pre-eclampsia and gestational hypertension with hyperuricemia." | 3.77 | First trimester uric acid and adverse pregnancy outcomes. ( Catov, J; Gandley, RE; Laughon, SK; Powers, RW; Roberts, JM, 2011) |
| " The biopsy findings of the placental bed were compared with adequate weight at birth related to gestational age, and to the following clinical parameters of the mother: arterial blood pressure, serum creatinine, serum uric acid and proteinuria." | 3.69 | Placental bed lesions and infant birth weight in hypertensive pregnant women. ( Costa, CA; Edelweiss, MI; Martins-Costa, S; Ramos, JG, 1995) |
| "Maximum serum uric acid (SUA) levels during the third trimester of pregnancy were selected in 215 hypertensive pregnant women: 100 with mild preeclampsia (PE), 25 with severe PE, 70 with essential hypertension (EH) and 20 with EH with superimposed PE (EH + PE)." | 3.67 | Uric acid levels: a useful index of the severity of preeclampsia and perinatal prognosis. ( Darbon-Grosso, HA; Illia, R; Imaz, FU; Margulies, M; Voto, LS, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (21.43) | 18.7374 |
| 1990's | 2 (14.29) | 18.2507 |
| 2000's | 1 (7.14) | 29.6817 |
| 2010's | 6 (42.86) | 24.3611 |
| 2020's | 2 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| de Mendonça, ELSS | 1 |
| da Silva, JVF | 1 |
| Mello, CS | 1 |
| de Oliveira, ACM | 1 |
| Zhao, X | 1 |
| Frempong, ST | 1 |
| Duan, T | 1 |
| Rothenbacher, D | 1 |
| Braig, S | 1 |
| Logan, CA | 1 |
| Feike, G | 1 |
| Müller, M | 1 |
| Koenig, W | 1 |
| Reister, F | 1 |
| Genuneit, J | 1 |
| Schmella, MJ | 1 |
| Clifton, RG | 1 |
| Althouse, AD | 1 |
| Roberts, JM | 3 |
| Laughon, SK | 1 |
| Catov, J | 1 |
| Powers, RW | 1 |
| Gandley, RE | 1 |
| Mattos, SS | 1 |
| Chaves, ME | 1 |
| Costa, SM | 1 |
| Ishigami, AC | 1 |
| Rêgo, SB | 1 |
| Souto Maior, V | 1 |
| Severi, R | 1 |
| de Lima Filho, JL | 1 |
| Hawkins, TL | 1 |
| Mangos, GJ | 1 |
| Davis, GK | 1 |
| Roberts, LM | 1 |
| Brown, MA | 1 |
| Akahori, Y | 1 |
| Masuyama, H | 1 |
| Hiramatsu, Y | 1 |
| Franco, MC | 1 |
| Kawamoto, EM | 1 |
| Gorjão, R | 1 |
| Rastelli, VM | 1 |
| Curi, R | 1 |
| Scavone, C | 1 |
| Sawaya, AL | 1 |
| Fortes, ZB | 1 |
| Sesso, R | 1 |
| Sibai, BM | 1 |
| Anderson, GD | 1 |
| Spinnato, JA | 1 |
| Shaver, DC | 1 |
| Ramos, JG | 1 |
| Martins-Costa, S | 1 |
| Edelweiss, MI | 1 |
| Costa, CA | 1 |
| Dunlop, W | 1 |
| Furness, C | 1 |
| Hill, LM | 1 |
| Ferrazzani, S | 1 |
| Caruso, A | 1 |
| De Carolis, S | 1 |
| Martino, IV | 1 |
| Mancuso, S | 1 |
| Voto, LS | 1 |
| Illia, R | 1 |
| Darbon-Grosso, HA | 1 |
| Imaz, FU | 1 |
| Margulies, M | 1 |
14 other studies available for uric acid and Infant, Small for Gestational Age
| Article | Year |
|---|---|
Serum uric acid levels associated with biochemical parameters linked to preeclampsia severity and to adverse perinatal outcomes.
Topics: Cross-Sectional Studies; Female; Humans; Hyperuricemia; Infant, Newborn; Infant, Newborn, Diseases; | 2022 |
Uric acid levels in gestational hypertensive women predict preeclampsia and outcome of small-for-gestational-age infants.
Topics: Female; Humans; Hypertension, Pregnancy-Induced; Infant; Infant, Newborn; Infant, Small for Gestatio | 2021 |
Association of maternal uric acid and cystatin C serum concentrations with maternal and neonatal cardiovascular risk markers and neonatal body composition: The Ulm SPATZ Health Study.
Topics: Adult; Birth Weight; Body Composition; Body Mass Index; Cardiovascular Diseases; Cystatin C; Female; | 2018 |
Uric Acid Determination in Gestational Hypertension: Is it as Effective a Delineator of Risk as Proteinuria in High-Risk Women?
Topics: Adolescent; Adult; Biomarkers; Clinical Trials as Topic; Female; Gestational Age; Humans; Hypertensi | 2015 |
First trimester uric acid and adverse pregnancy outcomes.
Topics: Adult; Female; Humans; Hypertension, Pregnancy-Induced; Hyperuricemia; Infant, Newborn; Infant, Smal | 2011 |
Which growth criteria better predict fetal programming?
Topics: Adult; Female; Fetal Blood; Fetal Development; Fetal Growth Retardation; Humans; Infant, Newborn; In | 2013 |
Plasma uric acid remains a marker of poor outcome in hypertensive pregnancy: a retrospective cohort study.
Topics: Adult; Algorithms; Antioxidants; Australia; Biomarkers; Cohort Studies; Female; Hematocrit; Hemoglob | 2012 |
The correlation of maternal uric acid concentration with small-for-gestational-age fetuses in normotensive pregnant women.
Topics: Adult; Birth Weight; Blood Pressure; Case-Control Studies; Creatinine; Female; Humans; Infant, Newbo | 2012 |
Biomarkers of oxidative stress and antioxidant status in children born small for gestational age: evidence of lipid peroxidation.
Topics: Antioxidants; Biomarkers; Birth Weight; Blood Pressure; Brazil; Censuses; Child; Cohort Studies; Cro | 2007 |
Plasma volume findings in patients with mild pregnancy-induced hypertension.
Topics: Adult; Creatinine; Female; Humans; Hypertension; Infant, Newborn; Infant, Small for Gestational Age; | 1983 |
Placental bed lesions and infant birth weight in hypertensive pregnant women.
Topics: Adult; Arteriosclerosis; Birth Weight; Creatinine; Female; Gestational Age; Humans; Hypertension; In | 1995 |
Maternal haemoglobin concentration, haematocrit and renal handling of urate in pregnancies ending in the births of small-for-dates infants.
Topics: Adult; Female; Hematocrit; Hemoglobins; Humans; Infant, Newborn; Infant, Small for Gestational Age; | 1978 |
Proteinuria and outcome of 444 pregnancies complicated by hypertension.
Topics: Adult; Birth Weight; Female; Fetal Death; Humans; Hypertension; Infant, Newborn; Infant, Small for G | 1990 |
Uric acid levels: a useful index of the severity of preeclampsia and perinatal prognosis.
Topics: Birth Weight; Female; Humans; Hypertension; Infant, Newborn; Infant, Small for Gestational Age; Pre- | 1988 |